Literature DB >> 22782017

Update on biliary and pancreatic sphincterotomy.

Yan Bakman1, Martin L Freeman.   

Abstract

PURPOSE OF REVIEW: To summarize the indications, success rates and complications associated with endoscopic sphincterotomy and endoscopic balloon dilation (EBD). RECENT
FINDINGS: Pancreatic and/or biliary sphincterotomies are essential components of most current therapeutic endoscopic retrograde cholangiopancreatography (ERCP). A current large body of evidence has established biliary sphincterotomy as effective in extraction of bile duct stones. The most common complications of biliary sphincterotomy are post-ERCP pancreatitis, as well as acute or delayed hemorrhage, the risks for which can be stratified according to well described patient and procedure related factors. Evidence is accumulating that pancreatic sphincterotomy is useful in at least some settings for treatment of sphincter of Oddi dysfunction, chronic pancreatitis, and pancreas divisum. EBD provides an adjunct or an alternative to biliary sphincterotomy for extraction of stones from the bile duct when routine biliary sphincterotomy is inadequate or risk excessive.
SUMMARY: Sphincterotomy and EBD are useful in managing a variety of pancreatobiliary conditions. Attention to risks of these procedures is essential for their efficacy and safety.

Entities:  

Mesh:

Year:  2012        PMID: 22782017     DOI: 10.1097/MOG.0b013e32835672f3

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  2 in total

Review 1.  Current role of non-anesthesiologist administered propofol sedation in advanced interventional endoscopy.

Authors:  Daniela Elena Burtea; Anca Dimitriu; Anca Elena Maloş; Adrian Săftoiu
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

2.  Outcomes of Hemospray therapy in the treatment of intraprocedural upper gastrointestinal bleeding post-endoscopic therapy.

Authors:  Mohamed Hussein; Durayd Alzoubaidi; Alvaro de la Serna; Michael Weaver; Jacobo O Fernandez-Sordo; Johannes W Rey; Bu'Hussain Hayee; Edward Despott; Alberto Murino; Sulleman Moreea; Phil Boger; Jason Dunn; Inder Mainie; David Graham; Dan Mullady; Dayna Early; Krish Ragunath; John Anderson; Pradeep Bhandari; Martin Goetz; Ralf Kiesslich; Emmanuel Coron; Enrique R de Santiago; Tamas Gonda; Laurence B Lovat; Rehan Haidry
Journal:  United European Gastroenterol J       Date:  2020-06-26       Impact factor: 4.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.